Item 7.01 Regulation FD Disclosure.

On November 7, 2022, Bionik Laboratories Corp. (the "Company") issued a press release to announce that the Company will present at the 2022 Investor Summit Q4 Micro-Cap Conference, where its President & Chief Executive Officer, Mr. Richard Russo Jr., will discuss the Company's new strategic direction and its 2022 highlights.

Mr. Russo's live presentation will take place at 9:00 AM (ET), Monday, November 14, 2022 at the Sheraton Times Square, 811 7th Avenue, W 53rd Street, New York, NY. A live webcast of the presentation can be accessed at https://us06web.zoom.us/webinar/register/WN_Gvp9yxgZRXCG-wNzRUsfHQ.

The press release, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K, is incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).

Item 9.01 Financial Statements and Exhibits.






Exhibit    Description
  99.1       Press release
104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses